Dicot Pharma AB

DB:KN0 Stock Report

Market Cap: €33.3m

Dicot Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:KN0 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Nov 24Buy€5,005Eva SaersIndividual243,210€0.021
25 Sep 24Buy€4,478Eva SaersIndividual320,000€0.014
24 Sep 24Buy€2,909Eva SaersIndividual200,000€0.015

Insider Trading Volume

Insider Buying: KN0 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KN0?
Owner TypeNumber of SharesOwnership Percentage
Private Companies49,593,6442.79%
Institutions101,443,3805.7%
Individual Insiders104,197,0995.86%
General Public1,523,545,71985.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 117.6%.

Top Shareholders

Top 15 shareholders own 14.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.06%
Avanza Fonder AB
89,983,020€1.7m0%0.02%
3.8%
Bertil Lindkvist
67,517,050€1.3m0%no data
1.57%
Skyddsprodukter I Sverige Finans Ab
28,000,000€524.5k0%no data
1.22%
Nordnet Pensionsförsäkring Ab, Asset Management Arm
21,679,883€406.1k0%0.08%
0.85%
Aktiebolaget Syoto
15,200,000€284.7k0%no data
0.56%
Kenneth Sjökvist
9,882,746€185.1k0%no data
0.51%
Klas Strömberg
9,000,000€168.6k0%no data
0.46%
Michael Zell
8,180,000€153.2k0%no data
0.37%
Gunilla Paalberg
6,598,202€123.6k0%no data
0.36%
Gryningskust FÖRvaltning Ab
6,393,644€119.8k0%no data
0.046%
Eva Saers
823,407€15.4k41.9%no data
0.037%
Elin Trampe
655,000€12.3k0%no data
0.036%
Goran Beijer
637,412€11.9k0%no data
0.034%
Per-Goran Gillberg
600,000€11.2k0%no data
0.017%
Charlotta Gauffin
303,282€5.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 12:47
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dicot Pharma AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution